HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia
This study uses electronic medical record data to compare 48-week viral load outcomes after starting long-acting antiretroviral therapy among people in the US with HIV with or without viremia from January 2021 through September 2024.
Authors
- Chesa Cox (ORCID: https://orcid.org/0000-0002-5918-2668)
- Matthew A. Spinelli (ORCID: https://orcid.org/0000-0001-6368-8664)
- David V. Glidden (ORCID: https://orcid.org/0000-0001-5888-1419)
- Megan J. Heise (ORCID: https://orcid.org/0000-0001-6651-2381)
- Janet R. Grochowski (ORCID: https://orcid.org/0000-0002-9816-7073)
- Monica Gandhi (ORCID: https://orcid.org/0000-0001-6674-5388)
- Jon Oskarsson
- Nathanial Gistand
Institutions
- University of California, San Francisco (US)
- University of California System (US)
Publication Details
- Journal
- JAMA
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1001/jama.2025.0109
- Citations
- 8
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 11.17